EEP in Patients With Urodynamically Proven DU/DA

Launched by EEPIDUDA STUDY GROUP · Jun 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a procedure called endoscopic, anatomic enucleation of the prostate (EEP) for men who have specific bladder issues known as detrusor underactivity (DU) or detrusor acontractility (DA). These conditions mean that the bladder muscles are not working properly, making it difficult to empty the bladder fully. The trial aims to create and evaluate a database of patients with these bladder problems who undergo the EEP procedure to better understand its effects.

To be eligible for this trial, participants must be male and have been diagnosed with DU or DA caused by factors not related to neurological conditions, such as Parkinson's disease or stroke. They should also not have undergone other types of prostate surgery for benign prostate enlargement. The trial is not yet recruiting participants, but once it starts, those who qualify can expect to contribute to valuable research that could improve treatment options for men with similar urinary issues.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• * Endoscopic enucleation of the prostate in patients with DU/DA secondary to a non-neurogenic aetiology:
• • Detrusor underactivity (DU) defined urodynamically as a bladder contractility index (BCI) of \<100.
• • Detrusor acontractility (DA) defined urodynamically as the absence of a detrusor contraction despite filling to bladder capacity.
• Exclusion Criteria:
• • Neurogenic aetiology for DU/DA (Parkinson, stroke...)
• • Other surgical approaches for the treatment of benign prostate hyperplasia (Aquaablation, open enucleation of the prostate, open prostatectomy, transurethral resection of the prostate...)